Stereotactic body radiation therapy (SBRT) for genitourinary malignancies

Stereotactic body radiation therapy (SBRT) is a novel treatment modality in radiation oncology that delivers a very high dose of radiation to the tumor target with high precision using single or a small number of fractions. SBRT is the result of technological advances in patient/tumor immobilization...

Full description

Saved in:
Bibliographic Details
Published inDiscovery medicine Vol. 10; no. 52; p. 255
Main Authors Teh, Bin S, Ishiyama, Hiromichi, Mathews, Thomas, Xu, Bo, Butler, E Brian, Mayr, Nina A, Lo, Simon S, Lu, Jiade J, Blanco, Angel I, Paulino, Arnold C, Timmerman, Robert D
Format Journal Article
LanguageEnglish
Published United States 01.09.2010
Subjects
Carcinoma, Renal Cell - radiotherapy
Humans
Male
Prostatic Neoplasms - radiotherapy
Radiosurgery - methods
Urogenital Neoplasms - radiotherapy
Online AccessGet more information

Cover

More Information
Summary:Stereotactic body radiation therapy (SBRT) is a novel treatment modality in radiation oncology that delivers a very high dose of radiation to the tumor target with high precision using single or a small number of fractions. SBRT is the result of technological advances in patient/tumor immobilization, image guidance, and treatment planning and delivery. This modality is safe and effective in both early stage primary cancer and oligometastases. Compared to the use of stereotactic radiosurgery for other tumor sites, SBRT is slow to be adopted in the management of genitourinary malignancies. There are now emerging data that show the safety and efficacy of this treatment modality in genitourinary (GU) malignancies especially in prostate cancer and renal cell carcinoma. Preclinical data, clinical experience, and challenges are reviewed and discussed.
ISSN:1944-7930